Mr. Trent Northcutt reports

AURORA SPINE ANNOUNCES INITIAL PATIENT ENROLLED FOR DEXA-CTM MULTICENTER STUDY

The first patient has been enrolled for Aurora Spine Corp.'s multicentre study of DEXA-CTM cervical interbody system. The commencement of the enrolment of patients indicates that the company has received all necessary approvals to launch the study, which will initially include data from 40 single-level and 40 multiple-level subjects.

Trent Northcutt, Aurora's president, chief executive officer and co-founder, stated: "The launch of the study is exciting news for Aurora and its DEXA platform technology. With this multicentre study now under way, we will be able to collect and provide important data to the medical industry about the DEXA-C device and technology platform."

Principal investigator Dr. Sebastian Koga, neurosurgeon at Forrest Health Institute of Neuroscience, said: "The study will document the impact of this new biomaterial on patient outcomes in the most rigorous way. Using a prospective multisite model will allow us to draw objective conclusions, with a focus on building confidence in adoption of the DEXA-C device by a wide range of clinicians."

The DEXA-C system is indicated for anterior cervical interbody fusion procedures and is the first in a series of implants based on Aurora's patented DEXA technology platform. Based on the DEXA T-score for measuring a patient's bone density, the DEXA technology platform includes implants that are of varying densities to match a patient's bone density. DEXA-C is intended for use on patients who require anterior cervical discectomy and fusion surgery. The DEXA-C system implants an interbody spacer(s) into the cervical intervertebral body space(s) to stabilize and fuse the level(s). Allograft will be used in the spacer and the spinal segment(s) are fixed with an anterior cervical plate.

About Aurora Spine Corp.

Aurora Spine is focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies.

We seek Safe Harbor.